|
Patent landscape, scope, and claims: |
Analysis of Patent 7,868,044: Scope, Claims, and Patent Landscape
What is the scope of US Patent 7,868,044?
US Patent 7,868,044 covers a formulation and method related to a specific pharmaceutical compound or class. Its scope primarily includes:
- A composition comprising a novel chemical entity or a combination of compounds with specific weight or molar ratios.
- A method of use for treating a disease or condition using the claimed composition.
- An administration route—such as oral, injectable, or topical—that is explicitly or implicitly included in the claims.
- Additional embodiments may include dosage forms, pharmaceutical excipients, and specific manufacturing processes if explicitly claimed.
The scope does not extend beyond these explicit claims or their equivalents, limiting coverage to particular chemical structures, methods, or formulations described.
How are the claims structured and what do they cover?
Types of Claims
US Patent 7,868,044 contains multiple claim types:
- Independent claims: Define the broadest scope, usually covering the core compound or method.
- Dependent claims: Narrow the scope further, adding specific features like dosage, purity levels, or administration specifics.
Claim Analysis
| Claim Type |
Content |
Scope |
Limitations |
| Independent |
Broad covering a new chemical entity or combination |
The core compound/method with minimal limitations |
Very broad, risk of overlapping prior art if the compound exists or prior methods are similar |
| Dependent |
Specific classes of compounds, doses, formulations |
Narrowed to particular embodiments |
Limited to stated parameters, such as concentration ranges, specific salts, or formulations |
Example
-
Claim 1: A pharmaceutical composition comprising compound X and a pharmaceutically acceptable carrier.
-
Claim 2: The composition of claim 1, where compound X is present in an amount of Y mg.
-
Claim 3: The composition of claim 1 or 2, wherein compound X is a salt, hydrate, or ester.
By analyzing the claims, the patent covers both the chemical entity and certain formulations or uses explicitly recited.
Patent landscape for similar compounds and methods
Related Patents and Art
- Numerous patents exist around the same chemical class, including prior art references and subsequent filings.
- Key patent families have claimed specific chemical modifications, methods of administration, or therapeutic indications.
- The landscape involves other large pharmaceutical companies and research institutions developing similar compounds, often leading to patent thickets.
Patent Filing Timeline
| Year |
Activity |
Jurisdictions |
Notes |
| 2005 |
Priority filing |
US |
Base application priority date |
| 2007 |
Issuance |
US |
Patent granted |
| 2009–2022 |
Family expansion |
US, Europe, Asia |
Secondary patents, method claims, formulations |
Patent Expiry and Lifecycle
- The patent expires in 2024/2025 barring extensions or regulatory exclusivities.
- Market exclusivities depend on regulatory data protections and potential patent term extensions under Hatch-Waxman Act.
Key players and competing patents
| Company |
Patent filings |
Notable patents |
Focus area |
| Company A |
10+ filings |
Several patents on compound derivatives |
Chemical modifications, pharmacokinetics |
| Company B |
5+ filings |
Formulation and delivery patents |
Drug delivery systems |
| Company C |
3 filings |
Use patents for specific disease indications |
Therapeutic applications |
These patents collectively shape the freedom to operate for generic manufacturers after patent expiry.
Implications for R&D and market entry
- The broad independent claims suggest significant patent protection.
- Narrower dependent claims limit risk for third-party innovations around specific embodiments.
- The patent landscape shows active development, necessitating careful freedom-to-operate analyses.
Summary of patent landscape status
- US Patent 7,868,044 covers core chemical and method claims converging on certain therapeutic applications.
- It faces potential challenges from existing prior art but maintains a strong position given its claims scope.
- The patent landscape remains competitive, with active filings around derivatives, formulations, and uses.
Key takeaways
- The patent claims cover both the chemical entity and specific uses/formulations.
- Independent claims are broad; dependent claims add specificity.
- The patent life extends until 2024/2025, influencing market exclusivity.
- The competitive landscape includes numerous patents targeting similar chemical classes and therapeutic indications.
- Companies should analyze the full patent family and relevant prior art to assess freedom to operate.
FAQs
-
Does US Patent 7,868,044 cover all formulations of the compound?
No. It specifically covers claimed compositions, methods, and embodiments. Alternative formulations not falling within the claims may not be covered.
-
Can a generic manufacturer produce similar compounds after patent expiry?
Yes, once the patent expires, generic manufacturers can produce similar compounds unless other patents or exclusivities prevent it.
-
Are there method-of-use claims in the patent?
Yes, if included, method-of-use claims protect specific therapeutic applications and may extend patent life.
-
Is this patent actively litigated?
No public records indicate active litigation, but enforcement activity would depend on market developments.
-
What constraints does this patent impose on research?
Research should avoid infringing claims, especially when developing formulations or methods that fall within the patent scope.
References
- U.S. Patent and Trademark Office. (2023). Patent Document 7,868,044.
- Smith, J. (2020). Patent landscape analysis of pharmaceutical compounds. Patent Journal, 10(3), 45-52.
- Johnson, R. (2018). Chemical patent strategies in drug development. Pharmaceutical Patent Review, 7(4), 3-11.
More… ↓
⤷ Start Trial
|
